Shimon Slavin
#122,229
Most Influential Person Now
Shimon Slavin's AcademicInfluence.com Rankings
Shimon Slavinphilosophy Degrees
Philosophy
#5576
World Rank
#8416
Historical Rank
Logic
#2833
World Rank
#3892
Historical Rank

Shimon Slavinbiology Degrees
Biology
#7467
World Rank
#10398
Historical Rank
Immunology
#405
World Rank
#420
Historical Rank

Download Badge
Philosophy Biology
Shimon Slavin's Degrees
- Doctorate Medicine University of California, San Francisco
- PhD Immunology Stanford University
Why Is Shimon Slavin Influential?
(Suggest an Edit or Addition)Shimon Slavin's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. (1998) (2131)
- Defining the intensity of conditioning regimens: working definitions. (2009) (1315)
- Correction of ADA-SCID by Stem Cell Gene Therapy Combined with Nonmyeloablative Conditioning (2002) (1143)
- Gene therapy for immunodeficiency due to adenosine deaminase deficiency. (2009) (926)
- Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. (2010) (880)
- Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study. (2009) (446)
- Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation. (1996) (431)
- Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) (2005) (428)
- Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin grafts (1977) (389)
- Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. (2008) (325)
- Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. (2008) (311)
- Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000. (2002) (270)
- Spontaneous murine B-cell leukaemia (1978) (255)
- Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy. (2007) (253)
- Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes. (1995) (233)
- Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors. (2016) (227)
- Mini-allografts: ongoing trials in humans (2000) (226)
- The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group (2010) (218)
- Autologous stem cell transplantation for progressive multiple sclerosis: Update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database (2006) (215)
- Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase. (2003) (210)
- Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal (2013) (200)
- Transplantation tolerance in adult rats using total lymphoid irradiation: permanent survival of skin, heart, and marrow allografts (1978) (193)
- Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): A proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases (2008) (192)
- Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma (2000) (191)
- MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1 (2013) (190)
- Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure? (2002) (189)
- Transplantation of allogeneic bone marrow without graft-versus-host disease using total lymphoid irradiation (1978) (176)
- Safety of retroviral gene marking with a truncated NGF receptor (2003) (168)
- Cannabidiol lowers incidence of diabetes in non-obese diabetic mice (2006) (163)
- T‐cell‐depleted allogeneic bone marrow transplantation for acute leukaemia using Campath‐1 antibodies and post‐transplant administration of donor's peripheral blood lymphocytes for prevention of relapse (1995) (162)
- The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD. (2004) (159)
- Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning. (2008) (157)
- T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. (2000) (156)
- Allograft Tolerance after Total Lymphoid Irradiation (TLI) (1979) (140)
- The role of imatinib mesylate (Glivec) for treatment of patients with malignant endocrine tumors positive for c-kit or PDGF-R. (2006) (138)
- Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study (2007) (134)
- Invasive fungal sinusitis in patients undergoing bone marrow transplantation. (1993) (134)
- Development of leukemia in donor cells after allogeneic stem cell transplantation--a survey of the European Group for Blood and Marrow Transplantation (EBMT). (2005) (134)
- Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor. (1993) (129)
- Right atrial thrombi are related to indwelling central venous catheter position: insights into time course and possible mechanism of formation. (1998) (127)
- The graft-versus-leukemia (GVL) phenomenon: is GVL separable from GVHD? (1990) (125)
- Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibody. (2000) (125)
- In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins (1982) (124)
- Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity? (2012) (121)
- Long-term survival of skin allografts in mice treated with fractionated total lymphoid irradiation. (1976) (121)
- Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide). (1993) (118)
- Cannabidiol arrests onset of autoimmune diabetes in NOD mice (2008) (117)
- Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens. (2006) (117)
- Adoptive transfer of immunity to hepatitis B virus after T cell–depleted allogeneic bone marrow transplantation (1993) (115)
- Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis. (2000) (113)
- Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation. (1993) (113)
- Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation. (2008) (112)
- MicroRNA-145 Is Downregulated in Glial Tumors and Regulates Glioma Cell Migration by Targeting Connective Tissue Growth Factor (2013) (111)
- Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation. (2001) (109)
- Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation (2008) (108)
- Recombinant human granulocyte-macrophage colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation with unpurged and purged marrow in non-Hodgkin's lymphoma: a double-blind placebo-controlled trial. (1992) (101)
- Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation. (1992) (98)
- Amelioration of diabetes in nonobese diabetic mice with advanced disease by linomide-induced immunoregulation combined with Reg protein treatment. (1998) (97)
- Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients. (1996) (92)
- A fludarabine-based protocol for bone marrow transplantation in Fanconi’s anemia (1997) (91)
- Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide (1993) (90)
- Stimulation of immune reconstitution by interleukin-7 after syngeneic bone marrow transplantation in mice. (1996) (89)
- Immunotherapy with recombinant human interleukin-2 and recombinant interferon-alpha in lymphoma patients postautologous marrow or stem cell transplantation. (1997) (88)
- A controlled trial of recombinant human erythropoietin after bone marrow transplantation. (1994) (87)
- Graft-versus-tumour and graft-versus-leukaemia effect in patient with concurrent breast cancer and acute myelocytic leukaemia (1996) (85)
- Fractionated Total Lymphoid Irradiation as Preparative Immunosuppression in High Risk Renal Transplantation: Clinical and Immunological Studies (1982) (85)
- A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR. (2010) (84)
- Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen (2001) (84)
- The potential use of adult stem cells for the treatment of multiple sclerosis and other neurodegenerative disorders (2008) (83)
- Anti-tumor effects of allogeneic bone marrow transplantation in (NZB X NZW)F1 hybrids with spontaneous lymphosarcoma. (1984) (83)
- Fibrin microbeads for isolating and growing bone marrow-derived progenitor cells capable of forming bone tissue. (2002) (82)
- A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease. (2007) (82)
- Conversion of red bone marrow into yellow - Cause and mechanisms. (2007) (82)
- Induction of allograft tolerance after total lymphoid irradiation (TLI): development of suppressor cells of the mixed leukocyte reaction (MLR). (1979) (78)
- Novel telomerase-increasing compound in mouse brain delays the onset of amyotrophic lateral sclerosis (2012) (78)
- Allogeneic cell therapy for a murine mammary carcinoma. (1998) (76)
- Inhibition of collagen synthesis and changes in skin morphology in murine graft-versus-host disease and tight skin mice: effect of halofuginone. (1996) (76)
- Natural killer cell HLA-C epitopes and killer cell immunoglobulin-like receptors both influence outcome of mismatched unrelated donor bone marrow transplants. (2005) (75)
- Induction of graft vs. tumor effect in a murine model of mammary adenocarcinoma (1997) (73)
- Allogeneic hematopoietic stem cell transplantation in children and adolescents with recurrent and refractory Hodgkin lymphoma: an analysis of the European Group for Blood and Marrow Transplantation. (2009) (72)
- Salvage high-dose chemotherapy for children with extragonadal germ-cell tumours (2005) (70)
- Nosocomial coagulase-negative staphylococcal infections in bone marrow transplantation recipients with central vein catheter. A 5-year prospective study. (1996) (69)
- Second allogeneic stem cell transplantation using nonmyeloablative conditioning for patients who relapsed or developed secondary malignancies following autologous transplantation. (2000) (68)
- Characterization of a spontaneous murine B cell leukemia (BCL1). I. Cell surface expression of IgM, IgD, Ia, and FcR. (1979) (68)
- Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2. (1994) (68)
- Chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE): treatment and induction of tolerance, with high dose cyclophosphamide followed by syngeneic bone marrow transplantation (1992) (67)
- The hematological etiology of osteoporosis. (2006) (67)
- Use of recombinant human interleukin-2 in conjunction with bone marrow transplantation as a model for control of minimal residual disease in malignant hematological disorders: I. Treatment of murine leukemia in conjunction with allogeneic bone marrow transplantation and IL-2-activated cell-mediated (1992) (67)
- Recombinant human superoxide dismutases: production and potential therapeutical uses. (1991) (65)
- Improved single-step PCR assay for sex identification post-allogeneic sex-mismatched BMT. (1996) (65)
- Low intensity regimens with allogeneic hematopoietic stem cell transplantation as treatment of hematologic neoplasia. (2000) (63)
- Donor lymphocyte infusions to displace residual host hematopoietic cells after allogeneic bone marrow transplantation for beta-thalassemia major. (1998) (62)
- Reconstruction of Cartilage, Bone, and Hematopoietic Microenvironment with Demineralized Bone Matrix and Bone Marrow Cells (2003) (60)
- Low‐dose γ‐irradiation promotes survival of injured neurons in the central nervous system via homeostasis‐driven proliferation of T cells (2004) (60)
- Neurologic manifestations in patients with mixed cryoglobulinemia (1974) (60)
- Immunobiology of a Spontaneous Murine B Cell Leukemia (BCL1) (1979) (60)
- Alloantigen persistence in induction and maintenance of transplantation tolerance (1987) (59)
- Immunotherapy of cancer with alloreactive lymphocytes. (2001) (59)
- Induction and mechanism of tolerance to bovine serum albumin in mice given total lymphoid irradiation (TLI). (1978) (58)
- Total lymphoid irradiation. (1987) (58)
- Allogeneic hematopoietic cell transplantation for fanconi anemia in patients with pretransplantation cytogenetic abnormalities, myelodysplastic syndrome, or acute leukemia. (2013) (58)
- Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients (2000) (57)
- TRANSMISSION OF BRUCELLOSIS BY BONE MARROW TRANSPLANTATION (1982) (57)
- Donor lymphocyte infusion post-non-myeloablative allogeneic peripheral blood stem cell transplantation for chronic granulomatous disease (1999) (55)
- Transplantation of allogeneic or xenogeneic bone marrow within the donor stromal microenvironment. (1999) (55)
- Treatment of post-hematopoietic stem cell transplantation hemorrhagic cystitis with intravesicular sodium hyaluronate (2006) (54)
- New strategies for bone marrow transplantation. (2000) (53)
- A longitudinal follow-up of salivary secretion in bone marrow transplant patients. (1995) (52)
- Antitumor effects of human recombinant interleukin-6 on acute myeloid leukemia in mice and in cell cultures. (1992) (52)
- Fludarabine-based protocol for human umbilical cord blood transplantation in children with Fanconi anemia. (1999) (52)
- Reduced-Intensity Allografting as First Transplantation Approach in Relapsed/Refractory Grades One and Two Follicular Lymphoma Provides Improved Outcomes in Long-Term Survivors. (2015) (52)
- Eradication of murine leukemia with histoincompatible marrow grafts in mice conditioned with total lymphoid irradiation (TLI) (1981) (52)
- Donor lymphocyte infusion: the use of alloreactive and tumor-reactive lymphocytes for immunotherapy of malignant and nonmalignant diseases in conjunction with allogeneic stem cell transplantation. (2002) (52)
- Immunotherapy of minimal residual disease by immunocompetent lymphocytes and their activation by cytokines. (1992) (51)
- Treatment of life-threatening autoimmune diseases with myeloablative doses of immunosuppressive agents: experimental background and rationale for ABMT. (1993) (51)
- CD44 Involvement in Autoimmune Inflammations (2007) (51)
- Total Lymphoid Irradiation Prevents Diabetes Mellitus in the Bio-Breeding/Worcester (BB/W) Rat (1984) (51)
- Allogeneic cell-mediated immunotherapy for breast cancer after autologous stem cell transplantation: a clinical pilot study. (1998) (50)
- Adoptive immunotherapy in conjunction with bone marrow transplantation--amplification of natural host defence mechanisms against cancer by recombinant IL-2. (1988) (50)
- Suppression and elimination of BCL1 leukemia by allogeneic bone marrow transplantation. (1983) (50)
- Immune response to polio vaccination in bone marrow transplant recipients. (1991) (50)
- Suppression of cell-mediated immune responses after total lymphoid irradiation (TLI). I. Characterization of suppressor cells of the mixed lymphocyte reaction. (1984) (50)
- Successful haematopoietic stem cell transplantation in 44 children from healthy siblings conceived after preimplantation HLA matching. (2014) (49)
- Use of recombinant human interleukin-2 in conjunction with syngeneic bone marrow transplantation in mice as a model for control of minimal residual disease in malignant hematologic disorders. (1991) (48)
- Enhanced marrow recovery by short preincubation of marrow allografts with human recombinant interleukin-3 and granulocyte-macrophage colony-stimulating factor. (1992) (48)
- Bone marrow transplantation using unrelated and family related donors: the impact of HLA-C disparity. (1996) (48)
- Immunomodulation of autoimmunity in MRL/lpr mice with syngeneic bone marrow transplantation (SBMT) (1995) (48)
- Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donors. (2006) (48)
- Results of genoidentical hemopoietic stem cell transplantation with reduced intensity conditioning for acute myelocytic leukemia: higher doses of stem cells infused benefit patients receiving transplants in second remission or beyond--the Acute Leukemia Working Party of the European Cooperative Grou (2006) (48)
- Allogeneic stem cell transplantation for severe acquired aplastic anaemia using a fludarabine‐based preparative regimen (2006) (48)
- Permanent and specific transplantation tolerance induced by a nonmyeloablative treatment to a wide variety of allogeneic tissues: I. Induction of tolerance by a short course of total lymphoid irradiation and selective elimination of the donor-specific host lymphocytes. (1997) (47)
- Proteasome inhibitors sensitize glioma cells and glioma stem cells to TRAIL-induced apoptosis by PKCε-dependent downregulation of AKT and XIAP expressions. (2011) (46)
- Development of antibodies to hepatitis B virus surface antigen in bone marrow transplant recipient following treatment with peripheral blood lymphocytes from immunized donors (1994) (46)
- Nonmyeloablative conditioning to induce bilateral tolerance after allogeneic bone marrow transplantation in mice. (1999) (45)
- Preimplantation Factor (PIF*) reverses neuroinflammation while promoting neural repair in EAE model (2012) (45)
- Osmotic behavior of normal and leukemic lymphocytes. (1975) (45)
- Graft-versus-lymphoma effect after allogeneic peripheral blood stem cell transplantation for primary central nervous system lymphoma. (1999) (45)
- Successful transplantation of haploidentically mismatched peripheral blood stem cells using CD133+-purified stem cells. (2005) (44)
- Peliosis Hepatis following treatment with androgen-steroids in patients with bone marrow failure syndromes (2007) (44)
- Preimplantation factor (PIF) analog prevents type I diabetes mellitus (TIDM) development by preserving pancreatic function in NOD mice (2011) (44)
- Effect of KRN7000 on induced graft-vs-host disease. (2004) (43)
- Interleukin-6 receptor-interleukin-6 fusion proteins with enhanced interleukin-6 type pleiotropic activities. (1997) (43)
- New developments in bone marrow transplantation. (1991) (43)
- The response of cord blood megakaryocyte progenitors to IL‐3, IL‐6 and aplastic canine serum varies with gestational age (1995) (43)
- Transplantation of bone marrow in outbred dogs without graft-versus-host disease using total lymphoid irradiation. (1979) (41)
- Rapid response to alefacept given to patients with steroid resistant or steroid dependent acute graft-versus-host disease: a preliminary report (2005) (40)
- CpG-induced myeloid CD11b+Gr-1+ cells efficiently suppress T cell-mediated immunoreactivity and graft-versus-host disease in a murine model of allogeneic cell therapy. (2008) (40)
- Osteogenic growth peptide increases blood and bone marrow cellularity and enhances engraftment of bone marrow transplants in mice. (1996) (40)
- Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases. (2005) (40)
- Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL (2016) (40)
- Cell Therapy With Preimmunized Effector Cells Mismatched for Minor Histocompatible Antigens in the Treatment of a Murine Mammary Carcinoma (2001) (40)
- Intracranial haematomas following bone marrow transplantation (1994) (40)
- Characterization of the spontaneous murine B cell leukemia (BCL1). III. Evidence for monoclonality by using an anti-idiotype antibody. (1979) (40)
- Nonmyeloablative stem cell transplantation: reduced-intensity conditioning for cancer immunotherapy--from bench to patient bedside. (2004) (39)
- Telomere Shortening Sensitizes Cancer Cells to Selected Cytotoxic Agents: In Vitro and In Vivo Studies and Putative Mechanisms (2010) (39)
- ELEVATED INFLAMMATORY CYTOKINE LEVELS IN BONE MARROW GRAFT REJECTION (1995) (39)
- Safety and efficacy of donor lymphocyte infusions following mismatched stem cell transplantation. (2006) (38)
- Enhancement of GVL effect with rhIL-2 following BMT in a murine model for acute myeloid leukemia in SJL/J mice. (1995) (38)
- Intracoronary administration of autologous bone marrow mononuclear cells after induction of short ischemia is safe and may improve hibernation and ischemia in patients with ischemic cardiomyopathy. (2005) (38)
- Low molecular weight heparin for hickman catheter‐induced thrombosis in thrombocytopenic patients undergoing bone marrow transplantation (1992) (38)
- Interstitial pneumonitis after total body irradiation: effect of partial lung shielding (1990) (38)
- Prevention and treatment of graft-versus-host disease by down-regulation of anti-host reactivity with veto cells of host origin (1999) (38)
- Effects of recombinant human granulocyte and granulocyte-macrophage colony-stimulating factors on neutrophil function following autologous bone marrow transplantation. (1991) (38)
- Induction of long-lasting antitumor immunity by concomitant cell therapy with allogeneic lymphocytes and trifunctional bispecific antibody. (2008) (37)
- Correction of enzyme deficiency in mice by allogeneic bone marrow transplantation with total lymphoid irradiation. (1980) (37)
- Low transplant-related mortality with allogeneic stem cell transplantation in elderly patients (2004) (37)
- Induction of antitumor immunity by indomethacin (2000) (36)
- Effects of CAMPATH-1 antibodies on the functional activity of monocytes and polymorphonuclear neutrophils. (1993) (36)
- The pathology and homing of a transplantable murine B cell leukemia (BCL1). (1979) (36)
- Clinical application of intrauterine bone marrow transplantation for treatment of genetic diseases--feasibility studies. (1992) (36)
- Functional clonal deletion versus active suppression in transplantation tolerance induced by total-lymphoid irradiation. (1985) (35)
- A retrospective review of the outcome after second or subsequent allogeneic transplantation. (2009) (35)
- Immunotherapy of relapsed resistant chronic myelogenous leukemia post allogeneic bone marrow transplantation with alloantigen pulsed donor lymphocytes (2001) (35)
- A partial characterization of suppressor cells in the spleens of mice conditioned with fractionated total lymphoid irradiation (TLI). (1983) (35)
- Transplantation tolerance after total lymphoid irradiation. (1979) (35)
- Inhibition of metastatic cell colonization in murine lungs and tumor‐induced morbidity by non‐peptidic Arg‐Gly‐Asp mimetics (1993) (34)
- Treatment with halofuginone results in marked growth inhibition of a von Hippel-Lindau pheochromocytoma in vivo. (2003) (34)
- Repair of bone defect using bone marrow cells and demineralized bone matrix supplemented with polymeric materials. (2010) (34)
- Spontaneous and IL-2-induced anti-leukemic and anti-host effects against tumor- and host-specific alloantigens. (1993) (34)
- Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome (2007) (33)
- Analysis of beta-globin mutations shows stable mixed chimerism in patients with thalassemia after bone marrow transplantation. (1995) (33)
- Non-myeloablative stem cell transplantation and donor lymphocyte infusion for the treatment of cancer and life-threatening non-malignant disorders. (2001) (33)
- Non-myeloablative stem cell transplantation for autoimmune diseases (2004) (33)
- Heparanase upregulates Th2 cytokines, ameliorating experimental autoimmune encephalitis. (2010) (33)
- Tolerance to donor-type skin in the recipient of a bone marrow allograft. Treatment of skin ulcers in chronic graft-versus-host disease with skin grafts from the bone marrow donor. (1985) (32)
- Ultrastructural, cell membrane, and cytogenetic characteristics of B-cell leukemia, a murine model of chronic lymphocytic leukemia. (1981) (32)
- PREVENTION OF GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA BY T-CELL DEPLETION INVITRO PRIOR TO TRANSPLANTATION (1985) (32)
- Osteoporosis of hematologic etiology. (2007) (31)
- The oxidative status of blood cells in a murine model of graft-versus-host disease (2007) (31)
- Prevention of diabetes in nonobese diabetic mice by nonmyeloablative allogeneic bone marrow transplantation. (2004) (31)
- Cancer immunotherapy with alloreactive lymphocytes. (2000) (31)
- Effect of cyclosporine A and methylprednisolone on the graft-versus-leukemia effects across major histocompatibility barriers in mice following allogeneic bone marrow transplantation. (1990) (31)
- Neuroprotection in multiple sclerosis (2006) (31)
- Prediction by a modified mixed leukocyte reaction assay of graft-versus-host disease and graft rejection after allogeneic bone marrow transplantation. (1994) (30)
- The antiangiogenic agent linomide inhibits the growth rate of von Hippel-Lindau paraganglioma xenografts to mice. (1999) (30)
- Allogeneic Cell‐Mediated and Cytokine‐Activated Immunotherapy for Malignant Lymphoma at the Stage of Minimal Residual Disease After Autologous Stem Cell Transplantation (1998) (30)
- Total Lymphoid Irradiation (1980) (29)
- Transplantation tolerance across major histocompatibility barriers after total lymphoid irradiation. (1979) (28)
- Prevention of diabetes mellitus in non-obese diabetic mice by Linomide, a novel immunomodulating drug (1994) (28)
- New Developments in the Therapy of Acute Myelocytic Leukemia. (2000) (28)
- ABO incompatibility is associated with increased non-relapse and GVHD related mortality in patients with malignancies treated with a reduced intensity regimen: a single center experience of 221 patients. (2008) (28)
- Induction of Tolerance to Experimental Anti‐Phospholipid Syndrome (APS) by Syngeneic Bone Marrow Cell Transplantation (1995) (27)
- Detection of minimal residual disease state in chronic myelogenous leukemia patients using fluorescence in situ hybridization. (1994) (27)
- Allogeneic hematopoietic stem cell transplantation in the elderly. (2007) (27)
- Nonmyeloablative allogeneic bone marrow transplantation as immunotherapy for hematologic malignancies and metastatic solid tumors in preclinical models. (2002) (27)
- Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies. (1999) (27)
- Successful immunization of autologous bone marrow transplantation recipients against hepatitis B virus by active vaccination. (1995) (27)
- Total lymphoid irradiation and kidney transplantation: a clinical experience. (1981) (26)
- Use of trifunctional bispecific antibodies to prevent graft versus host disease induced by allogeneic lymphocytes. (2006) (26)
- Oxidative stress protection by novel telomerase activators in mesenchymal stem cells derived from healthy and diseased individuals. (2013) (26)
- Intra‐arterial catheter directed therapy for severe graft‐versus‐host disease (2002) (26)
- Effect of total lymphoid irradiation (TLI) on the primary and secondary antibody response to sheep red blood cells. (1979) (26)
- T-cell depletion in allogeneic bone marrow transplantation: progress and problems. (1989) (26)
- Transplantation of Islet Cells Across Major Histocompatibility Barriers After Total Lymphoid Irradiation and Infusion of Allogeneic Bone Marrow Cells (1982) (25)
- Successful treatment of autoimmune disease in (NZB/NZW)F1 female mice by using fractionated total lymphoid irradiation. (1979) (25)
- Effect of exogenous recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor on neutrophil function following allogeneic bone marrow transplantation. (1991) (25)
- The number of infused CD34+ cells does not influence the incidence of GVHD or the outcome of allogeneic PBSC transplantation, using reduced-intensity conditioning and antithymocyte globulin (2010) (24)
- Cytokine production in Linomide-treated nod mice and the potential role of a Th (1)/Th(2) shift on autoimmune and anti-inflammatory processes. (2002) (24)
- Allogeneic cell therapy: the treatment of choice for all hematologic malignancies relapsing post BMT. (1996) (24)
- Total lymphoid irradiation in refractory systemic lupus erythematosus. (1986) (24)
- Functional clonal deletion versus suppressor cell-induced transplantation tolerance in chimeras prepared with a short course of total-lymphoid irradiation. (1986) (24)
- Effect of indomethacin on tumorigenicity and immunity induction in a murine model of mammary carcinoma (1998) (24)
- Immunotherapy of minimal residual disease in conjunction with autologous and allogeneic bone marrow transplantation (BMT). (1992) (23)
- Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: Getting closer to a cure? (2002) (23)
- Allogeneic cell-mediated immunotherapy of leukemia with immune donor lymphocytes to upregulate antitumor effects and downregulate antihost responses (2003) (23)
- IL-2 activated cell-mediated immunotherapy: control of minimal residual disease in malignant disorders by allogeneic lymphocytes and IL-2. (1990) (23)
- Selective CD4+ T-cell depletion does not prevent graft-versus-host disease. (1998) (23)
- Treatment of X‐linked childhood cerebral adrenoleukodystrophy by the use of an allogeneic stem cell transplantation with reduced intensity conditioning regimen (2005) (22)
- Linomide, a new treatment for autoimmune diseases: the potential in type 1 diabetes. (1993) (22)
- Typhlitis occurring in autologous bone marrow transplantation. (1992) (22)
- The role of the spleen in tumor growth kinetics of the murine B cell leukemia (BCL1). (1980) (22)
- The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. I. Effects of in vitro culturing with IL-3 and GM-CSF on human and mouse bone marrow cells purged with mafosfamide (ASTA-Z). (1989) (22)
- Ex vivo expansion of megakaryocyte precursors by preincubation of marrow allografts with interleukin-3 and granulocyte-macrophage colony-stimulating factor in vitro. (1995) (22)
- Allogeneic cell therapy of severe beta thalassemia major by displacement of host stem cells in mixed chimera by donor blood lymphocytes (1997) (22)
- Lymphocyte subpopulations in chronic active hepatitis: increase in lymphocytes forming stable E-rosettes. (1975) (22)
- Early-onset Guillain-Barré syndrome associated with reactivation of Epstein-Barr virus infection after nonmyeloablative stem cell transplantation. (2004) (22)
- Immunotherapy of hematologic malignancies and metastatic solid tumors in experimental animals and man. (2003) (21)
- New approaches for the prevention of rejection and graft-vs.-host disease in clinical bone marrow transplantation. (1986) (21)
- Linomide, an immunomodulator that inhibits Th1 cytokine gene expression. (1996) (21)
- The treatment of intractable rheumatoid arthritis with lymphoid irradiation. (1981) (21)
- Effects of human interleukin 3, macrophage and granulocyte-macrophage colony-stimulating factor on monocyte function following autologous bone marrow transplantation. (1992) (21)
- A non-myeloablative conditioning regimen in allogeneic stem cell transplantation from related and unrelated donors in elderly patients. (2006) (21)
- Soluble interleukin-6 receptors in hematology patients undergoing bone marrow transplantation. (1996) (20)
- Tumor‐cell vaccination induces tumor dormancy in a murine model of B‐cell leukemia/lymphoma (BCL1) (1996) (20)
- Adoptive immunotherapy with haploidentical allogeneic peripheral blood lymphocytes following autologous bone marrow transplantation. (2000) (20)
- Functional long-term thymidine kinase suicide gene expression in human T cells using a herpesvirus saimiri vector (2000) (20)
- Higher than expected transplant-related mortality and relapse following nonmyeloablative stem cell transplantation for lymphoma adversely effects progression free survival. (2000) (20)
- Immunotherapy in conjunction with autologous and allogeneic blood or marrow transplantation in lymphoma. (1998) (20)
- Partial protection of rat parotid glands from irradiation-induced hyposalivation by manganese superoxide dismutase. (2000) (20)
- The immunomodulator Linomide: role in treatment and prevention of autoimmune diabetes mellitus. (2001) (20)
- Immunotherapy of hematologic malignancies and metastatic solid tumors in experimental animals and man (2000) (20)
- Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity fludarabine-based regimen (2007) (20)
- Obstructive jaundice associated with carcinoma of the prostate. (1975) (20)
- The role of thiotepa in allogeneic stem cell transplantation in patients with leukemia. (1999) (20)
- Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders. (2003) (19)
- Second transplantation using allogeneic peripheral blood stem cells in a β‐thalassaemia major patient featuring stable mixed chimaerism (1996) (19)
- Treatment of pure red-cell aplasia following major ABO-mismatched T-cell-depleted bone marrow transplantation (1991) (19)
- The role of thiotepa in allogeneic bone marrow transplantation for genetic diseases (1999) (19)
- Nonmyeloablative stem cell transplantation for the treatment of cancer and life-threatening nonmalignant disorders: past accomplishments and future goals (2001) (19)
- Alternate donor hematopoietic cell transplantation (HCT) in non-Hodgkin lymphoma using lower intensity conditioning: a report from the CIBMTR. (2012) (19)
- Ciprofloxacin enhances hematopoiesis and the peritoneal neutrophil function in lethally irradiated, bone marrow-transplanted mice. (1994) (19)
- Split Immunity: Immune Inhibition of Rat Gliomas by Subcutaneous Exposure to Unmodified Live Tumor Cells (2011) (19)
- Therapeutic potential of recombinant granulocyte-macrophage colony-stimulating factor and interleukin-3 in murine B-cell leukemia. (1988) (19)
- Differential killing of murine B-cell leukemia (BCL1) by photosensitization with merocyanine 540: implications for autologous bone marrow transplantation. (1989) (19)
- Detection of minimal residual disease after sex-mismatch bone marrow transplantation in chronic myelogenous leukemia by fluorescence in situ hybridization. (1994) (18)
- Hematopoietic stem cell transplantation in multiple sclerosis: experimental evidence to rethink the procedures (2004) (18)
- Mixed cryoglobulinemia with a monoclonal IgM component, associated with chronic liver disease. (1972) (18)
- Toward amplification of a graft-versus-leukemia effect while minimizing graft-versus-host disease. (2000) (18)
- The role of antibodies to IL-2 receptor and Asialo GM1 on graft-versus-leukemia effects induced by bone marrow allografts in murine B cell leukemia. (1995) (18)
- Treatment of Leukemia by Alloreactive Lymphocytes and Nonmyeloablative Stem Cell Transplantation (2002) (18)
- Interleukin-7-enhanced cytotoxic T lymphocyte activity after viral infection in marrow transplanted mice (1997) (18)
- A Randomized Controlled Multicenter Study Comparing Recombinant Interleukin 2 (rIL-2) in Conjunction With Recombinant Interferon Alpha (IFN-α) Versus no Immunotherapy for Patients With Malignant Lymphoma Postautologous Stem Cell Transplantation (2010) (18)
- Bone marrow transplantation from a cadaveric donor (1998) (18)
- Use of total lymphoid irradiation in tissue transplantation in mice. (1977) (17)
- Salivary immunoglobulins in recipients of bone marrow grafts. I. A longitudinal follow-up. (1994) (17)
- Mycophenolate mofetil does not suppress the graft-versus-leukemia effect or the activity of lymphokine-activated killer (LAK) cells in a murine model (2005) (17)
- Heparanase prevents the development of type 1 diabetes in non‐obese diabetic mice by regulating T‐cell activation and cytokines production (2008) (17)
- Immunotherapy in high-risk chemotherapy-resistant patients with metastatic solid tumors and hematological malignancies using intentionally mismatched donor lymphocytes activated with rIL-2: a phase I study (2010) (17)
- Prevention of autoimmune diabetes by linomide in nonobese diabetic (NOD) mice is associated with up-regulation of the TCR-mediated activation of p21(ras). (1996) (17)
- Treatment of chronic myelogenous leukemia with recombinant human interleukin-2 and interferon-alpha 2a. (1994) (17)
- Clinical Outcomes of Patients with Desmoplastic Small Round Cell Tumor of the Peritoneum Undergoing Autologous HCT: a CIBMTR Retrospective Analysis (2012) (17)
- Ketotifen therapy in chronic graft‐versus‐host disease (cGVHD): effect on mast cells and fibroblasts (1995) (17)
- Optimal time interval between myeloablative whole body irradiation and reconstitution with syngeneic bone marrow graft. (1988) (16)
- Immunoglobulins A, G, and M to cytomegalovirus during recurrent infection in recipients of allogeneic bone marrow transplantation. (1991) (16)
- Potential use of interleukin-6 in bone marrow transplantation: effects of recombinant human interleukin-6 after syngeneic and semiallogeneic bone marrow transplantation in mice. (1994) (16)
- Role of interleukin-2 in human hematological malignancies (1995) (16)
- Heparanase Promotes Engraftment and Prevents Graft versus Host Disease in Stem Cell Transplantation (2010) (16)
- Gammopathy in liver disease. (1972) (16)
- RHU GM-CSF shortens aplasia duration after ABMT in non-Hodgkin's lymphoma: a randomized placebo-controlled double-blind study. (1991) (16)
- Excellent outcome of non-myeloablative stem cell transplant (NMSCT) for good risk myeloma: The EBMT experience (2000) (16)
- Successful treatment of autoimmune manifestations in MRL/l and MRL/n mice using total lymphoid irradiation (TLI). (1983) (16)
- Characterization of effector cells of graft vs leukemia following allogeneic bone marrow transplantation in mice inoculated with murine B-cell leukemia (2005) (16)
- Kidney allograft survival in dogs treated with total lymphoid irradiation. (1981) (16)
- Smarter rather than stronger treatment of haematological malignancies and non-malignant indications for stem-cell transplantation (2004) (16)
- Non-myeloablative allogeneic stem cell transplantation focusing on immunotherapy of life-threatening malignant and non-malignant diseases. (2001) (16)
- Minimal residual disease in murine B-cell leukemia (BCL1) detected by PCR. (1993) (15)
- IL-2-targeted therapy ameliorates the severity of graft-versus-host disease: ex vivo selective depletion of host-reactive T cells and in vivo therapy. (2012) (15)
- Telomerase activity and expression in adult human mesenchymal stem cells derived from amyotrophic lateral sclerosis individuals. (2009) (15)
- Lectin separation of nonlymphoid suppressor cells induced by total lymphoid irradiation (1985) (15)
- Bone marrow transplantation in thalassaemia. (1986) (15)
- Human Peripheral Blood Mononuclear Cells Incubated in Vasculogenic Conditioning Medium Dramatically Improve Ischemia/Reperfusion Acute Kidney Injury in Mice (2018) (15)
- Bone marrow transplantation with T-cell-depleted grafts. I. Reconstitution of immunohemopoietic functions in lethally irradiated mice transplanted with unseparated or T-cell-depleted syngeneic bone marrow grafts. (1986) (15)
- Purging breast cancer cells in preparation for autologous bone marrow transplantation. (1987) (15)
- Graft-versus-Host Disease, the Graft-versus-Leukemia Effect, and Mixed Chimerism following Nonmyeloablative Stem Cell Transplantation (2003) (15)
- Interstitial pneumonitis in T cell-depleted bone marrow transplantation. (1988) (14)
- Superoxide dismutase inhibits radiation-induced lung injury in hamsters (2004) (14)
- Low-dose heparin inhibits acute graft versus host disease in mice. (1993) (14)
- Successful T cell-depleted allogeneic bone marrow transplantation in a child with recurrent multiple extramedullary plasmacytomas. (1992) (14)
- A lupus-like syndrome due to lbuprofen hypersensitivity. (1980) (14)
- Immunomodulation of autoimmunity by linomide. (1995) (14)
- Herpesvirus saimiri pathogenicity enhanced by thymidine kinase of herpes simplex virus. (2000) (14)
- Potential Use of Interleukin-6 in Bone Marrow Transplantation: Effects of Recombinant Human Interleukin-6 After Syngeneic and Semiallogeneic Bone Marrow Transplantation in Mice (1994) (14)
- Depletion of donor-reactive cells as a new concept for improvement of mismatched bone marrow engraftment using reduced-intensity conditioning. (2004) (14)
- Preliminary characterization of functional residual host-type T lymphocytes following conditioning for allogeneic HLA-matched bone marrow transplantation (BMT). (1988) (14)
- Allogeneic Cell-Mediated Immunotherapy at the Stage of Minimal Residual Disease following High-Dose Chemotherapy Supported by Autologous Stem Cell Transplantation (2005) (14)
- Allogeneic stem cell transplantation for the treatment of diseases associated with a deficiency in bone marrow products (2004) (13)
- New insights into the pathophysiology of gastrointestinal graft-versus-host disease using capsule endoscopy. (2005) (13)
- Control of minimal residual cancer by low dose ipilimumab activating autologous anti-tumor immunity. (2014) (13)
- Treatment of pure red‐cell aplasia following major ABO‐mismatched T‐cell‐depleted bone marrow transplantation: Two case reports with successful response to plasmapheresis (1991) (13)
- Allogeneic cell-mediated immunotherapy for eradication of minimal residual disease: comparison of T-cell and IL-2 activated killer (LAK) cell-mediated adoptive immunotherapy in murine models. (1999) (13)
- Secretion of idiotypic IgM by the mouse B-cell leukaemia (BCL1) occurs spontaneously in vitro and in vivo. (1985) (13)
- In vivo T-cell dynamics during immune reconstitution after hematopoietic stem cell gene therapy in adenosine deaminase severe combined immune deficiency. (2011) (13)
- Allogeneic CD3/CD28 cross-linked Th1 memory cells provide potent adjuvant effects for active immunotherapy of leukemia/lymphoma. (2009) (13)
- Activated long-term peripheral blood cultures as preparation for adoptive alloreactive cell therapy in cancer patients. (1997) (13)
- Activated allogeneic cell therapy (allo-ACT) for relapsed chronic myelogenous leukemia (CML) refractory to buffy coat transfusions post-allogeneic bone marrow transplantation. (1996) (13)
- Allogeneic versus syngeneic killer splenocytes as effector cells for the induction of graft-versus-tumor effect. (2004) (13)
- Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts. (1988) (13)
- The anti-tumor effect of allogeneic bone marrow/stem cell transplant without graft vs. host disease toxicity and without a matched donor requirement? (2008) (13)
- Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies. (1996) (13)
- Survey on haematopoietic stem cell transplantation for children in Europe (2005) (12)
- Allogeneic hematopoietic stem cell transplantation in ovarian cancer—the EBMT experience (2010) (12)
- In vivo CAMPATH‐1 monoclonal antibodies: A novel mode of therapy for acute graft‐versus‐host disease (1996) (12)
- Immunosuppression and tolerance after total lymphoid irradiation (TLI). (1980) (12)
- Removal of breast cancer cells by soybean agglutinin in an experimental model for purging human marrow. (1988) (12)
- Elimination of graft versus host disease in matched allogeneic leukemic transplant recipients using CAMPATH-1. (1985) (12)
- Allogeneic cell therapy in murine B-cell leukemia (BCL1): 2. The role of non-activated and rIL-2-activated CD4+ and CD8+ T cells in immunotherapy for leukemia. (1999) (12)
- The use of total lymphoid irradiation (TLI) as immunosuppressive therapy for organ allotransplantation and autoimmune diseases. (1981) (12)
- A novel approach for prevention of lethal GVHD by selective elimination of alloreactive donor lymphocytes prior to stem cell transplantation. (2004) (11)
- Indolent aspergillus arthritis complicating fludarabine-based non-myeloablative stem cell transplantation (2001) (11)
- Generation of protein-specific and alloantigen-specific suppressor cells following total lymphoid irradiation in mice. (1979) (11)
- CD40 ligand-specific antibodies synergize with cyclophosphamide to promote long-term transplantation tolerance across MHC barriers but inhibit graft-vs-leukemia effects of transplanted cells. (2003) (11)
- The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (2008) (11)
- The use of total lymphoid irradiation for allogeneic bone marrow transplantation in animals and man (1985) (11)
- Continuous intravenous administration of rmGM-CSF enhances immune as well as hematopoietic reconstitution following syngeneic bone marrow transplantation in mice. (1993) (11)
- Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies (2020) (11)
- Murine B-cell leukemia lymphoma (BCL1) cells as a target for NK cell-mediated immunotherapy (2004) (11)
- In vitro and in vivo cytokine-induced facilitation of immunohematopoietic reconstitution in mice undergoing bone marrow transplantation. (1988) (11)
- Neutropenic enterocolitis and intestinal perforation associated with carboplatin-containing conditioning regimen for autologous bone marrow transplantation. (1992) (11)
- Reduced-intensity conditioning or nonmyeloablative stem cell transplantation: introduction, rationale, and historic background. (2004) (11)
- The use of total lymphoid irradiation (TLI) for prevention of rejection of T-lymphocyte depleted bone marrow allografts in non-malignant hematological disorders. (1989) (11)
- Mesenchymal progenitor cells in red and yellow bone marrow. (2009) (11)
- Marrow transplantation in multiple myeloma. (1992) (10)
- Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantation. (2008) (10)
- Improved survival following induction of GVHD following lipopolysaccharide immunization. (2006) (10)
- Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Patients with Acute Lymphoblastic Leukemia (ALL): A Survey from the European Group for Blood and Marrow Transplantation (EBMT). (2005) (10)
- Effect of deoxyspergualin on graft-versus-host disease and graft- versus-leukemia in mice. (1996) (10)
- Cytogenetic analysis of the spontaneous murine B-cell leukemia (BCL1). (1980) (10)
- Effector cells of graft-versus-host disease, host resistance, and the graft-versus-leukemia effect: summary of a workshop on bone marrow transplantation. (1987) (10)
- Induction of graft-versus-leukemia (GVL) effect without graft-versus-host disease (GVHD) by pretransplant donor treatment with immunomodulators. (2009) (10)
- Long-term enzyme replacement therapy in beta-glucuronidase--deficient mice by allogeneic bone marrow transplantation. (1982) (10)
- The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. II. The influence of lymphokines on CFU-GM colonies from human untreated, ASTA-Z or Campath-1M treated bone marrow. (1990) (10)
- Bone marrow transplantation in beta-thalassemia major. The Israeli experience. (1988) (10)
- Completely mismatched allogeneic CD3/CD28 cross-linked Th1 memory cells elicit anti-leukemia effects in unconditioned hosts without GVHD toxicity. (2008) (10)
- Interleukin-7 induced facilitation of immunological reconstitution of sublethally irradiated mice following treatment with alloreactive spleen cells in a murine model of B-cell leukemia/lymphoma (BCL1) (2007) (10)
- Induction of early post-transplant graft-versus-leukemia effects using intentionally mismatched donor lymphocytes and elimination of alloantigen-primed donor lymphocytes for prevention of graft-versus-host disease. (2005) (10)
- Effect of various cytokine combinations on induction of non-MHC-restricted cytotoxicity. (1993) (10)
- Effect of bone marrow T lymphocytes treated with CAMPATH 1G on megakaryocyte colony formation. (1993) (10)
- Activation of the recombination activating gene 1 (RAG-1) transcript in bone marrow of senescent C57BL/6 mice by recombinant interleukin-7. (1999) (10)
- Successful treatment of diabetes in NOD mice with advanced disease by islet isografts following immunoregulation with Linomide (quinoline-3-carboxamide). (1996) (10)
- Non-myeloablative stem cell transplantation for the treatment of cancer and life-threatening non-malignant disorders; past accomplishments and future goals. (2002) (10)
- Herbal flavonoids inhibit the development of autoimmune diabetes in NOD mice: proposed mechanisms of action in the example of PADMA 28 (2010) (10)
- Future strategies in hematopoietic stem cell transplantation for rheumatoid arthritis. (2001) (10)
- Total lymphoid irradiation, anti-lymphocyte globulin and Campath 1-G for immunosuppression prior to bone marrow transplantation for aplastic anemia after repeated graft rejection. (1994) (9)
- Prevention and treatment of relapse by bone marrow transplantation. (1993) (9)
- Non-myeloablative allogeneic stem cell transplantation for the treatment of patients with chronic myeloid leukemia (2000) (9)
- The novel immunomodulator, Linomide, stimulates interleukin-2-induced human natural killer (NK) cell and PHA-stimulated T cell proliferation from normal donors. (1996) (9)
- Hemopoietic activity in bone marrow chimeras prepared with total lymphoid irradiation (TLI). (1982) (9)
- Immunosuppression and Organ Transplantation Tolerance Using Total Lymphoid Irradiation (1980) (9)
- Intrahepatic arterial administration of low-dose methotrexate in patients with severe hepatic graft-versus-host disease: an open-label, uncontrolled trial. (2004) (9)
- Long-Term Safety and Efficacy of Gene Therapyfor Adenosine Deaminase (ADA)-Deficient Severe Combined Immunodeficiency (2009) (9)
- Natural cell-mediated cytotoxicity in mice treated with total lymphoid irradiation (TL1). (1982) (9)
- Use of total lymphoid irradiation (TLI) in bone marrow and organ transplantation. (1979) (9)
- Current problems and future goals in clinical bone marrow transplantation. (1988) (9)
- In-vitro T cell mediated function in patients with active rheumatoid arthritis. (1981) (9)
- A case of adrenogenital syndrome with aberrant 11beta-hydroxylation. (1977) (9)
- Post transplant persistence of host cells augments the intensity of acute graft-versus-host disease and level of donor chimerism, an explanation for graft-versus-host disease and rapid displacement of host cells seen following non-myeloablative stem cell transplantation? (2006) (8)
- Post-hematopoietic stem cell transplantion immune-mediated cytopenias. (2009) (8)
- Induction of mixed hematopoietic chimerism and specific transplantation tolerance to allogeneic and xenogeneic grafts by selective elimination of donor-reactive host cells following nonmyeloablative conditioning. (1997) (8)
- The effect of in vitro T lymphocyte depletion on generation of IL2-activated cytotoxic cells. (1991) (8)
- Cell mediated autoimmune granulocytopenia in a case of Felty's syndrome. (1980) (8)
- Non-myeloablative stem cell transplantation for induction of host-versus-graft tolerance for adoptive immunotherapy of malignant and nonmalignant diseases and towards transplantation of organ allografts. (2002) (8)
- Pretransplant treatment of donors with immunomodulators to control graft-versus-host disease (GVHD) in transplant recipients. (2007) (8)
- Monoclonal rat anti-human lymphocyte antibody Campath-1 binds to T and B lymphocytes but effectively lyses only T cells. (1987) (8)
- Immunohematopoietic reconstitution by allogeneic and autologous bone marrow grafts as a means for induction of specific unresponsiveness to donor-specific allografts and modified self in autoimmune disorders. (1993) (8)
- Induction of graft versus leukemia effects by cell-mediated lymphokine-activated immunotherapy after syngeneic bone marrow transplantation in murine B cell leukemia (1996) (8)
- Salivary immunoglobulins in recipients of bone marrow grafts. II. Transient secretion of donor-derived salivary IgA following transplantation of T cell-depleted bone marrow. (1994) (8)
- Immunological evaluation of patients with hematological malignancies receiving ambulatory cytokine-mediated immunotherapy with recombinant human interferon-α2a and interleukin-2 (1992) (8)
- Reduced intensity versus truly nonmyeloablative conditioning for stem-cell transplant recipients. (2004) (8)
- Synthetic, Non-Natural Analogs of Ceramide Elevate Cellular Ceramide, Inducing Apoptotic Death to Prostate Cancer Cells and Eradicating Tumors in Mice (2010) (8)
- Bone marrow transplantation with T-cell-depleted grafts. II. Reconstitution of immunohemopoietic functions in lethally irradiated mice transplanted with unseparated or T-cell-depleted bone marrow grafts disparate at minor histocompatibility antigens. (1987) (8)
- Control of relapse due to minimal residual disease (MRD) by cell-mediated cytokine-activated immunotherapy in conjunction with bone marrow transplantation. (1991) (8)
- Spontaneous murine b cell leukemia (mbl1). An animal model for human chronic lymphocytic leukemia. Abstr. (1978) (8)
- Immune modulation by ionized irradiation. (1988) (8)
- Membrane Type 1-Matrix Metalloproteinase Is Directly Involved in G-CSF Induced Human Hematopoietic Stem and Progenitor Cell Mobilization. (2004) (8)
- P-261 Ovarian failure post-chemotherapy in young cancer patients-risk assessment indicate the need for intervention (1997) (7)
- Human T cells recovered from human/Balb radiation chimeras are hypersensitive to human immunodeficiency virus type 1 infection (1997) (7)
- Treatment of Resistant Leukemia by rIL-2 Activated NK Cells in Recipients of HLA Matched and Haploidentically Mismatched Stem Cell Allografts while Avoiding GVHD. (2004) (7)
- Use of matched or mismatched rIL-2 activated donor lymphocytes positively selected for CD56+ for immunotherapy of resistant leukemia after allogeneic stem cell transplantation (2004) (7)
- Irradiated mononuclear cells express significant in vitro cytotoxic activity: promise for in vivo clinical efficacy of irradiated mismatched donor lymphocytes infusion. (2014) (7)
- Mechanisms of transplantation tolerance to allogeneic bone marrow cells following total lymphoid irradiation (TLI). (1980) (7)
- Human mesenchymal stromal cells ameliorate complement induced inflammatory cascade and improve renal functions in a rat model of ischemia-reperfusion induced acute kidney injury (2019) (7)
- Correlation between enhancement of graft-versus-leukemia effects following allogeneic bone marrow transplantation by rIL-2 and increased frequency of cytotoxic T-lymphocyte precursors in murine myeloid leukemia. (2000) (7)
- Transient elevation of serum lactic dehydrogenase following autologous bone marrow transplantation. (1991) (7)
- Eosinophils activation in post-autologous bone marrow transplanted patients treated with subcutaneous interleukin-2 and interferon-alpha 2A immunotherapy. (1994) (7)
- Cytokine-mediated immunotherapy following autologous bone marrow transplantation in lymphoma and evidence of interleukin-2-induced immunomodulation in allogeneic transplants. (1997) (7)
- Spinal epidural lipomatosis following haploidentical allogeneic bone marrow transplantation for non‐Hodgkin lymphoma (2004) (7)
- Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disorders. (1987) (7)
- Interleukin-3 in combination with granulocyte-macrophage-colony-stimulating factor following bone marrow transplantation in a radiation accident victim (1994) (7)
- Lectin-binding properties of Burkitt's lymphoma cell lines: application to bone marrow purging. (1990) (7)
- Total lymphoid irradiation (TLI) and allogeneic marrow transplantation for enzyme replacement therapy and immunotherapy of leukemia in mice. (1981) (7)
- CD44 gene vaccination for insulin-dependent diabetes mellitus in non-obese diabetic mice. (2008) (7)
- Minitransplants and cell-based therapies for malignant and nonmalignant disorders (1999) (7)
- Rapid and Wide Immunereconstitution Obtained with HSV-TK Engineered Donor Lymphocyte Add-Backs Permits Long-Term Survival after haplo-HSCT. (2006) (7)
- Long-term effects of splenectomy on immunocompetent cells of adult mice. (1980) (7)
- Recombinant Human Interleukin-6 Accelerates In-Virto Megakaryocytopoiesis and Platelet Recovery Post Autologous Peripheral Blood Stem Cell Transplantion (1995) (7)
- Immunotherapy in conjunction with autologous bone marrow transplantation. (1990) (7)
- A new minimally ablative stem cell transplantation procedure in high-risk patients not eligible for nonmyeloablative allogeneic bone marrow transplantation (2003) (6)
- Soluble IL-6 receptors (sIL-6R) in hematological patients receiving immunotherapy with IL-2/IFN-alpha or donor lymphocytes following bone marrow transplantation. (1996) (6)
- The importance of patient selection in nonmyeloablative stem cell transplant (NMSCT) for acute and chronic leukaemia, myelodysplastic syndrome, and myeloma (2000) (6)
- Maternal-fetal relationship, natural chimerism and bilateral transplantation tolerance as the basis for non-myeloablative stem cell transplantation (2002) (6)
- Enrichment for GM-CFU from human bone marrow using Sambucus nigra agglutinin: potential application to bone marrow transplantation. (1986) (6)
- The CRST syndrome. (1971) (6)
- Immunomodulatory effects of linomide in animals immunized with immunopathogenic retinal antigens: dissociation between different immune functions (1997) (6)
- Hematopoietic stem cell therapy for malignant diseases (2007) (6)
- Involvement of interleukin-2 in immunologic reconstitution following bone marrow transplantation in mice. (1995) (6)
- Normal hematopoietic reconstitution following ASTA-Z 7557-purged grafts in the absence of in vitro CFU-GM colony growth. (1993) (6)
- N-acetylcysteine mildly inhibits the graft-vs.-leukemia effect but not the lymphokine activated cells (LAK) activity. (2007) (6)
- Differential effects of CD4+ and CD8+ cells on lymphocyte development from human cord blood cells in murine fetal thymus explants. (1999) (6)
- Nonmyeloablative bone marrow transplantation based on deletion of host-anti-donor alloreactive cells prevents autoimmune insulitis and diabetes in nonobese diabetic mice. (2002) (5)
- Immunoregulation of GVHD by triggering the innate immune system with CpG (2009) (5)
- Induction of Bilateral Transplantation Tolerance to Cellular and Perfused Allografts and Xenografts with Donor Hematopoietic Cells a (1998) (5)
- Inhibition of leukemic cell proliferation by one or more factors released from splenic BCL1 cells. (1995) (5)
- The Use of Soybean Agglutinin (SBA) for Bone Marrow (BM) Purging and Hematopoietic Progenitor Cell Enrichment in Clinical Bone Marrow Transplantation. (1999) (5)
- Combination of magnetic and chemocytotoxic cancer cell depletion for autologous bone marrow transplantation. (1988) (5)
- Transplantation of hematopoietic stem cells for induction of unresponsiveness to organ allografts (2004) (5)
- The effect of T lymphocyte depletion on susceptibility to influenza virus infection and development of anti-viral immunity in lethally irradiated mice reconstituted with syngeneic bone marrow grafts. (1987) (5)
- Intraportal and systemic allogeneic cell therapy in a murine model of hepatic metastatic breast cancer. (2002) (5)
- Lessons from bone marrow transplantation for a victim of a radiological accident with acute radiation syndrome (2005) (5)
- The effect of high-dose thiotepa, alone or in combination with other chemotherapeutic agents, on a murine B-cell leukemia model simulating autologous stem cell transplantation (2007) (5)
- Deletion of donor-reactive cells as a new conditioning regimen for allogeneic bone marrow transplantation. (2007) (5)
- The effect of pegylated antisense acetylcholinesterase on hematopoiesis. (2003) (5)
- Time to engraftment following allogeneic stem cell transplantation is significantly longer in patients with myelodysplastic syndrome than with acute myeloid leukemia (2008) (5)
- Failure of cyclosporine to induce graft-vs-host disease or graft-vs-leukemia after syngeneic bone marrow transplantation in mice. (1996) (4)
- Donor lymphocyte infusions for hematopoietic malignancy. (2002) (4)
- Should soybean agglutinin purging be performed in breast cancer patients undergoing autologous stem cell transplantation? A retrospective analysis of 48 patients. (1997) (4)
- Cytokine gene transduction into non-immunogeneic murine tumor cells. (1998) (4)
- Intra-Arterial Catheter Directed Immunosuppressive Therapy for Steroid Resistant or Dependent Graft vs. Host Disease (GVHD). (2007) (4)
- The role of thiotepa in autologous bone marrow transplantation for acute leukemia. (1998) (4)
- Effect of Linomide on adhesion molecules, TNF-α, nitrogen oxide, and cell adhesion (2005) (4)
- Autologous and Allogenic Stem Cell Transplantation for the Treatment of Autoimmune Diseases as a Potential New Approach (1999) (4)
- Multiformic modulation of endotoxin effects by linomide. (1999) (4)
- Clinical implications of monoclonal gammopathy in chronic liver disease (1974) (4)
- Immunotherapy of murine leukemia following non-myeloablative conditioning with naïve or G-CSF mobilized blood or bone marrow stem cells (2004) (4)
- A method for isolating pluripotent/multipotent stem cells from blood by using the pluripotent and germ-line DAZL gene as a marker. (2009) (4)
- Development of Secondary Anaplastic Oligoastrocytoma after Matched Unrelated Bone Marrow Transplantation in a Child with Acute Myeloid Leukemia (2003) (4)
- Induction of tumor immunity by intact irradiated leukemic B cells (BCL1) bearing a tumor-associated cell-surface idiotype and the costimulatory B7 molecule (1995) (4)
- Autologous bone marrow transplantation for stage IV neuroblastoma: the role of soybean agglutinin purging. (1993) (4)
- The effect of total or partial T lymphocyte depletion on susceptibility to influenza virus infection and development of antiviral immunity in lethally irradiated mice reconstituted with immune syngeneic bone marrow grafts. (1991) (4)
- The effect of linomide, an immunoregulator in experimental autoimmune diseases, on humoral antibody responses in mice. (1997) (4)
- Induction of cell-mediated IL-2-activated antitumor responses in conjunction with autologous and allogeneic bone marrow transplantation. (1991) (4)
- Toward improvement of therapeutic strategies in leukemia by amplification of the immune responses against leukemia. (1990) (3)
- Regulation of the immune response in experimental models of autoimmune disorders: resistance of (NZB X NZW)F1 mice to tolerance induction in vivo. (1983) (3)
- 379: Intra-arterial Catheter Directed Immunosuppressive Therapy for Steroid Resistant or Dependent Graft vs. Host Disease (GVHD) (2008) (3)
- Interleukin 2 regulation following semi-allogeneic bone marrow transplantation in mice (2006) (3)
- Trisenox (Arsenic Trioxide) in the Treatment for Multiple Myeloma after Bone Marrow Transplantation. (2005) (3)
- Continuous Interleukin-2 Infusion Combined with Cyclophosphamide- Based Combination Chemotherapy in the Treatment of Hemato-Oncological Malignancies (1998) (3)
- Review : Modulation of experimental systemic lupus erythematosus with linomide (1996) (3)
- Selective elimination of alloreactivity in vitro and in vivo while sparing other T-cell-mediated immune responses (2012) (3)
- Salivary immunoglobulins in recipients of bone marrow grafts. III. A longitudinal follow-up of CMV specific antibodies. (1996) (3)
- New approaches for control of anti-self-reactivity in type 1 diabetes and transplantation of pancreatic islets. (1997) (3)
- A Phase II Multicenter Trial of HSV-TK Engineered Donor Lymphocytes after Haplo-Identical HSCT: Early Immune Reconstitution and Abrogation of Gvhd. (2004) (3)
- Inhibition of Tumors in Mice Models by a Synthetic Ceramide-analog AD2725 (2016) (3)
- Bone Marrow Transplantation for Cancer and Autoimmunity (2000) (3)
- Depletion of alloantigen-primed lymphocytes overcomes resistance to allogeneic bone marrow in mildly conditioned recipients. (2004) (3)
- The Impact of Allogeneic Hematopoietic Stem Cell Transplantation in Children and Adolescents with Recurring Hodgkin’s Lymphoma: An EBMT Study on 151 Patients. (2007) (3)
- Induction of transplantation tolerance by intraportal injection of allogeneic bone marrow cells: Possible implications for intrauterine bone marrow transplantation across major histocompatibility barriers (1988) (3)
- Protooncogenes and autoimmunity. (1997) (3)
- ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA USING CAMPATH-1 MONOCLONAL-ANTIBODIES AND POSTTRANSPLANT ALLOIMMUNIZATION WITH DONOR LYMPHOCYTES (1993) (3)
- Selective abrogation of alloreactivity via priming in the presence of aphidicolin, a specific inhibitor of DNA polymerase. (1989) (3)
- Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myelogenous Leukemia. (2006) (3)
- RESISTANCE OF T SUPPRESSOR CELLS TO CYCLOPHOSPHAMIDE ADMINISTRATION IN TOTAL‐LYMPHOID-IRRADIATED MICE (1983) (3)
- Induction of transplantation tolerance by intraportal injection of allogeneic bone marrow cells (1988) (3)
- Successful Treatment of Diabetes in Nod Mice with Advanced Disease by Islet Isografts following Immunoregulation with Linomide (Quinoline-3-Carboxamide) (1996) (3)
- Single and double stranded DNA binding lymphocytes in the peripheral blood of patients with systemic lupus erythematosus and normal controls. (1979) (3)
- Allogeneic cell therapy in murine B-cell leukemia (BCL1): 1. Alloimmune-mediated graft-versus-leukemia (GVL) effects induced by unmodified and in vitro rIL-2-activated bone marrow and lymphocytes from different lymphoid compartments. (1999) (3)
- Regulation of the immune response in experimental models of autoimmune disorders: I. Immunocompetence and transplantation tolerance in female (NZB X NZW)F1 hybrid mice immunosuppressed with total lymphoid irradiation and in reconstituted bone marrow chimeras. (1983) (3)
- The role of recombinant cytokines and other immunomodulators on engraftment following allogeneic bone marrow transplantation in mice. (1992) (3)
- Ganciclovir for the treatment of disseminated CMV disease without pneumonia in allogeneic T-lymphocyte depleted bone marrow transplantation. (1993) (3)
- New approaches for control of anti-self reactivity in type 1 diabetes mellitus and transplantation of pancreatic islets (1999) (3)
- Successful matched unrelated transplantation from a donor with idiopathic thrombocytopenic purpura (ITP) (1995) (3)
- Effects of interleukin 2 on engraftment following autologous bone marrow transplantation (ABMT) in dogs. (1992) (3)
- Reactivity of Human Monoclonal Antibody Campath-1 with Human Leukemia Lymphoma Cell Lines of Varying Maturation. (1990) (3)
- Investigations on the role of inflammatory and anti-inflammatory agents on the treatment of murine B cell leukemia by recombinant human interleukin-2. (1993) (2)
- Donor activating KIR influence outcome post unrelated stem cell transplantation (2004) (2)
- A 2‐DAY MLR PROCEDURE FOR MARROW DONOR SELECTION FOR ALLOGENEIC BONE MARROW TRANSPLANTATION (1993) (2)
- Severe migratory polyarthritis following in vivo CAMPATH-1G. (1995) (2)
- Is There a Role for ASCT in Patients with Desmoplastic Small Round Cell Tumor of the Peritoneum (2011) (2)
- The clinically validated viral superinfection therapy (SIT) platform technology could cure early cases of COVID-19 disease (2021) (2)
- INTERLEUKIN-18 (IL-18) And IL-18 binding protein (IL-18bp) And acute graft versus host disease (Gvhd) (2000) (2)
- HSV-TK Engineered Donor Lymphocytes Add-Backs Reduce Late Mortality and Improve Survival of High Risk Acute Leukemia after Haplo-HSCT: Results of a Phase II Multicenter Trial. (2005) (2)
- Suppressor T cells in allogeneic bone marrow chimeras. (1987) (2)
- Anti-rIL-2 receptor antibodies and marrow aplasia (2003) (2)
- ANTILEUKEMIC EFFECTS OF ALLOGENEIC BONE MARROW ALLOGRAFTS IN MICE (1982) (2)
- Rhinolalia as a presenting sign of pneumomediastinum complicating post peripheral blood stem cell transplantation bronchiolitis obliterans (2003) (2)
- Linomide administration following bone marrow transplantation in mice (2002) (2)
- Chronic liver disease associated with mixed cryoglobulinemia. Review of the literature and presentation of two cases. (1972) (2)
- [Bone marrow transplantation]. (1995) (2)
- Serum transcobalamin levels as an early indicator of bone marrow engraftment following transplantation (1983) (2)
- Infusions of HSV-TK Engineered Donor Lymphocytes Effectively Protect Patients Undergoing Haploidentical Stem Cells Trasplantation (HSCT) from Infectious Mortality. (2007) (2)
- Nonmyeloablative stem cell transplantation using lymphoablative rather than myeloablative conditioning in the prefludarabine era by ATG and limiting doses of cyclophosphamide (2005) (2)
- Effect of total lymphoid irradiation on natural killer cells and cytotoxic and primed T lymphocytes. (1994) (2)
- Enhancement of hematopoietic reconstitution with recombinant cytokines: effect of rhIL-6 in combination with rhGM-CSF and rhIL-3 on unmodified or T cell-depleted bone marrow. (1999) (2)
- 380: Alefacept Treatment for Chronic Extensive Graft Versus Host Disease (2008) (2)
- Immunoregulation rather than immunosuppression for prevention and treatment of autoimmune disorders. (1996) (2)
- Effect of recombinant human manganese superoxide dismutase on radiosensitivity of murine B cell leukemia (BCL1) cells. (1993) (2)
- Cell-mediated immunity in idiopathic autoimmune haemolytic disease. (1975) (2)
- Prevention of allograft rejection by induction of specific transplantation tolerance with immunomanipulation using total lymphoid irradiation. (1980) (2)
- Bone marrow transplantation in beta-thalassemia major with prevention of graft-vs-host disease. (1988) (2)
- The role of activated T lymphocytes in megakaryocytopoiesis (1992) (2)
- Normalization of serum lactic dehydrogenase in β‐thalassemia patients following bone marrow transplantation (1996) (2)
- The role of suppressor T lymphocytes in the maintenance of tolerance to alloantigens in bone marrow chimeras prepared with total lymphoid irradiation (TLI). (1985) (2)
- Recombinant human interleukin-6 accelerates in-vitro megakaryocytopoiesis and platelet recovery post autologous peripheral blood stem cell transplantation. (1995) (2)
- The Use of Bone Marrow Derived Mesenchymal Stromal Cells for Treatment of Patients with Multiple Sclerosis and Neurodegenerative Disorders – Achievements and Future Goals (2012) (1)
- Towards Possible Cure of Cancer by Immunotherapy of Minimal Residual (2015) (1)
- Use of total lymphoid irradiation (TLI) for the treatment of autoimmune disorders. (1988) (1)
- [Aplastic anemia following acute viral hepatitis associated with hypogammaglobulinemia--attempted treatment by bone marrow transplantation]. (1975) (1)
- Transfer of B memory cells to a T-dependent antigen in murine bone marrow transplantation. (1987) (1)
- BONE MARROW TRANSPLANTATION WITH T‐CELL-DEPLETED GRAFTS (1986) (1)
- Non-myeloblative stem-cell transplantation for immunotherapy of cancer and non-malignant diseases with allogeneic lymphocytes. (2002) (1)
- MIXED CHIMERISM FOLLOWING NON- MYELOABLATIVE STEM CELL TRANSPLANTATION (NST) TO INDUCE TRANSPLANTATION TOLERANCE TO BONE MARROW AND ORGAN ALLOGRAFTS (2000) (1)
- The use of parabiosis for investigating the mechanism of transplantation tolerance in bone marrow chimeras induced by total lymphoid irradiation (1990) (1)
- Total lymphoid irradiation used as an experimental method of immunosuppression therapy in bone marrow and whole organ allotransplantation (1978) (1)
- 305: Thymoglobulin® Rabbit Anti-thymocyte Globulins (r-ATG) Induces Faster Platelet Recovery and does not Suppress Granulocyte Engraftment in a Non-myeloablative Stem Cell Transplantation Setting (2008) (1)
- Shifting Towards Better Immunotherapy Rather Than More Intensive Chemoradiotherapy Using a Non-Myeloablative Approach in Patients with Leukemia (2001) (1)
- Excretion of liver antigens in the urine of patients with hepatic diseases (1976) (1)
- A clinically validated, broadly active, oral viral superinfection therapy could mitigate symptoms in early-stage COVID-19 patients. (2022) (1)
- Allogeneic stem cell transplantation (SCT) from hla matched family donors other than siblings (2000) (1)
- Deletion of donor-reactive cells followed by stem cell transplantation in recipients treated with total lymphoid-irradiation as a means for induction of transplantation tolerance to organ allografts and xenografts. (1998) (1)
- Targeting non-engrafting IL-2 activated intentionally mismatched donor lymphocytes with monoclonal or bispecific antibodies for treatment of otherwise incurable cancer. (2020) (1)
- Depletion of human lymphocytes from peripheral blood and bone marrow by affinity ligands conjugated to agarose—polyacrolein microsphere beads (1986) (1)
- Depletion of alloreactive T cells for tolerance induction in a recipient of kidney and hematopoietic stem cell transplantations (2012) (1)
- HLA and acute graft vs host disease (GVHD) following allogeneic bone marrow transplantation (BMT) (1994) (1)
- Non-myeloablative stem cell transplantation (Nst) For the treatment of malignant and non-malignant diseases (2000) (1)
- lymphoma: myeloablative or reduced intensity? Conditioning regimens for allotransplants for diffuse large B-cell (2012) (1)
- Optimization of conditioning therapy for leukemia prior to BMT. I. Optimal synergism between cyclophosphamide and total body irradiation for eradication of murine B cell leukemia (BCL1). (1993) (1)
- Fludarabine based low intensity conditioning protocol for unrelated matched stem cell transplantation (NST/MUD) in chronic myelogenous leukemia(CML) (2000) (1)
- Prevention and treatment of type I diabetes in NOD mice by linomide. (1995) (1)
- Adoptive transfer of resistance to Pseudomonas aeruginosa infection by splenocytes and bone marrow cells from BALB/c mice immunized by pseudomonas aeruginosa lectin preparations (1989) (1)
- Successful engraftment following allogeneic stem cell transplantation in very high-risk patients with busulfan as a single agent. (2005) (1)
- Erratum to: Preimplantation factor (PIF) analog prevents type I diabetes mellitus (TIDM) development by preserving pancreatic function in NOD mice (2011) (1)
- Use of matched or mismatched rIL-2 activated donor lymphocytes positively selected for CD56+ for immunotherapy of resistant leukemia after allogeneic stem cell transplantation. (2004) (1)
- Total Lymphoid Irradiation for Immunosuppression (1985) (1)
- SUPPRESSOR MECHANISMS IN TISSUE TRANSPLANTATION TOLERANCE FOLLOWING TOTAL LYMPHOID IRRADIATION (TLI) (1979) (1)
- Induction of tolerance to self antigens through bone marrow transplantation (BMT) as a therapeutic approach in acute and chronic relapsing (CR-EAE) experimental autoimmune encephalomyelitis (1991) (1)
- [Human umbilical cord blood as a source of hematopoietic progenitor cells for transplantations]. (1995) (1)
- A CASE OF ADRENOGENITAL SYNDROME WITH ABERRANT (2008) (0)
- Modulation of immunoreactivity towards transplantation tolerance across mhc using total lymphoid irradiation. Abstr. (1981) (0)
- Reactivity in a modified MLR test correlates with bone marrow transplantation outcome in patients (1992) (0)
- Tolerance in bone marrow & organ transplantation : achievements & goals (1984) (0)
- BONE MARROW TRANSPLANTATION: EXPERIMENTAL AND CLINICAL ASPECTS (1982) (0)
- Chemotherapy Foundation: Innovative Cancer Therapy for Tomorrow--XVII Symposium. 3-6 November 1999, Mount Sinai School of Medicine, New York, NY, USA. (2000) (0)
- Duration to Engraftment Requires Significantly Much More Time in Myelodysplastic Syndrome (MDS) Patients as Compared to Acute Myeloid Leukemia (AML) Patients Following Allogeneic Stem Cell Transplantation. (2005) (0)
- Allogeneic Hematopoietic Stem Cell Transplantation for Autoimmune Diseases (2019) (0)
- Protective role of bone marrow cells in controlling alloreactivity. (2003) (0)
- [Hematopoietic growth factor (GM-CSF) after autologous bone marrow transplantation. A randomized, double-blind, multicenter study in 91 cases of non-Hodgkin's malignant lymphomas]. (1993) (0)
- CD 44 Gene Vaccination for Insulin-Dependent Diabetes Mellitus in Non-Obese Diabetic Mice (0)
- Immunologic approaches for breast cancer patients in the setting of stem cell transplantation (1999) (0)
- Transplantation from Related and Unrelated Donors in Elderly Patients - Equal Toxicity and Survival. (2006) (0)
- Simultaneous Haploidentically Mismatched Stem Cell Transplantation from Multi-Donors (MDT) in Humans Offers Better Engraftment as Compared to Single Haploidentical Donor. (2007) (0)
- Towards Possible Cure of Cancer by Immunotherapy of Minimal Residual Disease Using Intentionally Mismatched Donor Lymphocytes (2020) (0)
- 400 Four-month outcome and safety of intracoronary autologous bone marrow infusion for the treatment of sever ischemic cardiomyopathy with evidence of hibernating myocardium (2004) (0)
- The use of fludarabine based reduced intensity conditioning for the treatment of patients with Fanconi’s anemia (2004) (0)
- Treatment of advanced disease in NOD mice by immunomodulation and expansion of B-cell mass: a combined approach (2009) (0)
- Diagnostic, prevention et traitement du diabete (1998) (0)
- is significantly longer in patients with myelodysplastic syndrome than with acute myeloid leukemia (2008) (0)
- Long-term clinical studies of high-risk renal retransplant recipients given total lymphoid irradiation. (1989) (0)
- Long-Term Outcome of Nonmyeloablative Allogeneic Stem Cell Transplantation in First Chronic Phase of Chronic Myeloid Leukemia (2006) (0)
- of minimal residual disease in malignant hematologic disorders control syngeneic bone marrow transplantation in mice as a model for Use of recombinant human interleukin-2 in conjunction with (2011) (0)
- Post-irradiated canine serum (PICS-J) stimulates megakaryocyte (MK) progenitors and thrombopoiesis in-vitro (1996) (0)
- Innovative immunotherapy for prevention and treatment of relapse following conventional chemotherapy or stem cell transplantation (2016) (0)
- Abstract session I–Transplantation (2004) (0)
- 1004. Integration Analyses in ADA-Deficient SCID Patients Successfully Treated with Stem Cell Gene Therapy (2004) (0)
- 296: Simultaneous Haploidentically Mismatched Stem Cell Transplantation from Multi-donors (MDT) in Humans Offers better Engraftment as Compared to Single Haploidentical Donor (2008) (0)
- Feasibility and toxicity of high-dose chemotherapy with/without BCNU for autologous bone marrow transplantation (ABMT) in breast carcinoma (1993) (0)
- P085 Treatment of steroid refractory graft vs. host disease by intra-arterial infusion (2007) (0)
- 20 Years of Experience with Hematopoietic Stem Cell Transplantation for β-Thalassemia Major. (2005) (0)
- P083 Simultaneous haploidentically mismatched stem cell transplantation from multi-donors (MDT) in humans offers better engraftment as compared to single donor (2007) (0)
- Autologous bone marrow transplantation (ABMT) for non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD): The role of immunotherapy (1993) (0)
- Inhibition of Mutant FLT3 Activation by the Novel Tyrphostin, AGS324. (2005) (0)
- Is locus C matching important in bone marrow transplantation (1994) (0)
- Successful purging of murine plasmacytoma by mafosfamide (ASTA-Z). (1994) (0)
- Effect of RTVP-1 on the mesenchymal transformation of glioma stem cells (GSCs) and their self-renewal and migration. (2013) (0)
- lymphoma: a double- blind placebo-controlled trial transplantation with unpurged and purged marrow in non-Hodgkin's factor after high-dose chemotherapy and autologous bone marrow Recombinant human granulocyte-macrophage colony-stimulating (2013) (0)
- Effect of Linomide on adhesion molecules, TNF-alpha, nitrogen oxide, and cell adhesion. (2005) (0)
- Successful treatment of chronic-relapsing experimental autoimmune encephalomyelitis with linomide (LS-2616) (1991) (0)
- Leukemia 2000: towards the cure. 7-9 September 2000, Houston, TX, USA. (2000) (0)
- Felty ' s syndrome . granulocytopenia in a case of Cell mediated autoimmune (0)
- Matching for HLA NK epitopes reduces AGVHD and improves survival in one haplotype matched bone marrow transplants (2003) (0)
- BONE MRROY TRANSPLANTATION IN B-TWIASSEUIA UAJOR (1988) (0)
- Tumorigenicity and immunogenicity in a murine model of B-cell leukemia/lymphoma (BCL1). (1998) (0)
- Allogeneic bone marrow transplatation for correction of enzyme deficiency in mice using total lymphoid irradiation. Abstr. (1980) (0)
- Infusion of suicide gene-modified donor T cells promotes a rapid and effective immune reconstitution and provides long-term survival after haploidentical hemaopoietic cell transplantation for the cure of patients with high-risk leukemia (2008) (0)
- Cellular Therapy by Non-Myeloablative Stem Cell Transplantation and Immunotherapy of Minimal Residual Disease (1999) (0)
- malignancies relapsing post BMT (letter; comment) Allogeneic cell therapy: the treatment of choice for all hematologic (2011) (0)
- Quinazolinone-containing drug and methods for their use (1995) (0)
- Regulation of the immune response in experimental models of autoimmune disorders. II. Induction of suppressor cells of the mixed lymphocyte culture in adult (NZB x NZW)F1 mice using total lymphoid irradiation. (1983) (0)
- Immunotherapy by Allogeneic Lymphocytes and Cytokines Following Autologous and Allogeneic Bone Marrow Stem Cell Transplantation (2020) (0)
- 5th International Conference on Clinical Hematology and Transfusion Medicine (2020) (0)
- Serum cytokines in patients with chronic myelogenous leukemia treated with IL-2 and aIFN (1991) (0)
- Triaryl compounds and compositions comprising the same (2008) (0)
- Successful engraftment following allogeneic stem cell transplantation with busulfan as a (2005) (0)
- allogeneic bone marrow transplantation recombinant human interleukin-2 to treat leukemia relapse after Allogeneic cell therapy with donor peripheral blood cells and (2011) (0)
- Adoptive Transfer of Immunity to Hepatitis B Through Bone Marrow Transplantation from Immunized Donors (1994) (0)
- State-of-the-Art Review Donor Lymphocyte Infusion: The Use of Alloreactive and Tumor-Reactive Lymphocytes for Immunotherapy of Malignant and Nonmalignant Diseases in Conjunction with Allogeneic Stem Cell Transplantation (2002) (0)
- T-cell depleted bone marrow transplantation for plasma cell myeloma (1988) (0)
- Donor Immunization Vaccination and Transfer of Donor Immunity to Bone Marrow Transplant Recipients in the Course of Allogeneic Cell Therapy for Prevention and Treatment of Relapse (1998) (0)
- Graft-versus-leukemia : experimental results (1993) (0)
- [Autologous stem cell transplantation breast cancer with distant metastases]. (1998) (0)
- Immunotherapy in high-risk, chemotherapy-resistant patients with metastatic solid tumors and hematologic malignancies using intentionally mismatched donor lymphocytes activated with rIL-2: A phase II study. (2010) (0)
- Radiosensitivity and responsiveness to recombinant interleukin-2 of effector cells of graft vs. host disease and mixed lymphocyte reaction in mice. (1992) (0)
- Reduced-intensity allografting as first transplantation approach in relapsed/refractory grade 1-2 follicular lymphoma provides improved outcomes in long-term survivors Biol Blood Marrow Transplant (2015) (0)
- The Role of Proto-Oncogenes in Autoimmunity (1999) (0)
- Fatal acute cardiomyopathy associated with “non‐cardiotoxic” chemotherapy for autologous bone marrow transplantation (1992) (0)
- Infusions of HSV-TK genetically modified donor lymphocytes enable a wider use of partially mismatched allogeneic transplantation by reducing infection related mortality and improving survival in high risk acute leukemia. (2006) (0)
- 88. Antitumor effects of human IL-6 in murine leukemia and solid tumor models (1992) (0)
- Bone marrow & organ transplantation : achievements & goals (1984) (0)
- Vivo in Inhibition of a von Hippel-Lindau Pheochromocytoma Treatment with Halofuginone Results in Marked Growth (2003) (0)
- Unmodified Live Tumor Cells Gliomas by Subcutaneous Exposure to Split Immunity : Immune Inhibition of Rat (2011) (0)
- Amplification of Graft vs Malignancy (GVM) Effects by Using Intentionally Mismatched Donor Lymphocytes While Avoiding Graft-vs-Host Disease in Conjunction with Haploidentically Mismatched Stem Cell Allografts in Patients with Hematological Malignances. (2006) (0)
- Chapter-08 The Use of Non-myeloablative Stem Cell Transplantation (NST) for the Treatment of Malignant and Non-malignant Diseases (2006) (0)
- Bone marrow transplantation across major histocompatibility barriers in mice treated with fractionated total lymphoid irradiation. Abstr. (1977) (0)
- Resistance to mycobacteria in mice treated with fractionated total lymphoid irradiation (TLI) and in mice reconstituted with allogenic bone marrow cells following radiotherapy. (1985) (0)
- Non-myeloablative stem cell transplantation in newly established donor stromal microenvironment for facilitation of hematopoietic reconstitution (2004) (0)
- Effective Treatment of Resistant Hematological Malignancies by IL-2 Activated NK Cells Using Haploidentically Mismatched Donors by Induction of Graft-Versus-Tumor (GVT) Effect While Avoiding GVHD. (2005) (0)
- Commentary (Slavin): Nonmyeloablative Preparative Regimens for Allogeneic Hematopoietic Transplantation (2003) (0)
- O-148 Prevention of vaginal hemorrhage in thrombocytopenic cancer patients during chemotherapy treatments (1997) (0)
- Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma. (2001) (0)
- Proceedings of the 2nd Meeting of the Asian Cellular Therapy Organization (2011) (0)
- Visualization of immune response kinetics in full allogeneic chimeras. (2011) (0)
- Nonmyeloablative Allogeneic Stem Cell Transplantation: Towards Improving Efficacy of Immunotherapy Instead of Myeloablative Chemoradiotherapy (2000) (0)
- Allogeneic cell therapy as potential cure of hematologic malignancies (2020) (0)
- Breakthrough notions in Hematology and Transfusion Medicine: Market Scrutiny (2020) (0)
- [The role of interleukin-2--based immunotherapy in hematological malignancies]. (1996) (0)
- Cell therapy of cancer with alloreactive intentionally mismatched IL-2 activated donor lymphocytes targeting anti-cancer killer NK & T cells using monoclonal and bispecific antibodies (2015) (0)
- Early and Effective Immune-Recovery by Gene-Engineered Lymphocytes after Haploidentical Transplantation for Leukemia Abate Late Transplant Mortality (2008) (0)
- Induction of tumor dormancy in BALB/C mice against nonimmunogenic b cell leukemia (2017) (0)
- Stem Cells as Targets for Gene and Cell Therapy (2005) (0)
- Efficacy of high dose chemotherapy with/without BCNU for autologous bone marrow transplantation (ABMT) in breast cancer (1993) (0)
- Assessment of the Immune Reconstitution by Cylex Immuknow™ Assay in Patients after Allogeneic Stem Cell Transplantation. (2006) (0)
- Transient recovery of endogenous immune function following haploidentical peripheral stem cell transplantation in a patient with severe combined immunodeficiency without evidence of engraftment (2000) (0)
- The use of melatonin and co-treatment with autologous or allogeneic cells as a model for control of malignant beta-cell leukemia. (1999) (0)
- Lymphokine mediated immuno-therapy (1995) (0)
- Enhancement of Hematopoietic Stem Cell Engraftment and Graft vs. Leukemia Effect Induced by Matched and Haploidentically Mismatched Allograft Using Multi-Donor Stem Cell Transplantation (MDT). (2006) (0)
- LAB-STEM CELLS (2012) (0)
- Enhancement of primary and secondary responses to sheep red blood cells and influenza virus in BALB/c mice by recombinant human interleukin-2. (1996) (0)
- N-Acetylcysteine Mildly Inhibits the Graft vs Leukemia Effect but Not the Lymphokine Activated Cells (LAK) Activity. (2006) (0)
- Megakaryocyie growth factors in sera of throbocytopenic patients undergoing chemotherapy, radiotherapy or allogeneic bone marrow transplantation (1993) (0)
- Engraftment following low dose total body irradiation (Tbi) (200 Cgy)/fludarabine (Flu) Nonmyeloablative conditioning for allogeneic stem cell transplants (alloSCT) (2000) (0)
- [Immunosuppression and induction of tolerance by fractionated total lymphoid irradiation]. (1985) (0)
- Induction of Anti-Cancer Effects by Targeting Alloreactive Intentionally Mismatched T Cells and NK Cells to Tumor Cells Using Bi-Specific Trifunctional Antibodies. (2006) (0)
- Immunotherapy of lymphoma by cytokines and allogeneic cell therapy (1999) (0)
- myeloid leukemia in mice and in cell cultures Antitumor effects of human recombinant interleukin-6 on acute (2011) (0)
- The use of soybean agglutinin (SBA) for bone marrow (BM) purging and hematopoietic progenitor cell enrichment in clinical bone-marrow transplantation. (1999) (0)
- Traitement ou prevention du diabete a l'aide de cannabidiol (2005) (0)
- Lichenoid reaction in bone marrow transplants suffering from chronic GVHD is associated with HLA-DQW1 (1992) (0)
- ASTA-Z 7557 impairs human natural killer (NK) cell activity. (1996) (0)
- Demonstration and characterization of virus released by murine B cell leukemia cells (BCL1). (1984) (0)
- Post transplant immunotherapy for prevention of relapse after autologous bmt for acute leukemia (1998) (0)
- Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL (2016) (0)
- Biological response modifiers as adjuncts to stem cell transplantation (2006) (0)
- Use of halofuginone for the manufacture of a medicament for the prevention of neovascularization and for the treatment of malignant tumors (1996) (0)
- Results of Allogeneic Hematopoietic Cell Transplantation in Persons with Fanconi Anemia and Pretransplant Cytogenetic Abnormalities, Myelodysplastic Syndrome, or Acute Leukemia (2011) (0)
- Treatment of patients with metastatic solid tumors with intentionally mismatched lymphocytes activated with rIL-2 in the outpatient setting. (2004) (0)
- Enhanced lymphoid cell recovery after bone marrow transplantation: correlation with the presence of costimulatory antibodies in serum. (1998) (0)
- Thymoglobulin ® Rabbit Anti-Thymocyte Globulins (r-ATG) Induces Faster Platelet Recovery and Does Not Suppress Granulocyte Engraftment in a Non-Myeloablative Stem Cell Transplantation Setting. (2007) (0)
- Bone marrow transplantation across major histocompatibility barriers: mechanisms and applications. Abstr. (1981) (0)
- THE CANCER REVOLUTION Additional Material for Appendix 1 Prof . (2016) (0)
- Proliferative response of murine B-cell leukemia (BCL1) to poly(L-lysine). (1985) (0)
- The use of autologous mesenchymal stromal cells for treatment of neurodegenerative disorders - past achievements and future goals (2013) (0)
- [Value of partial protection of lung tissue for prevention of radiation pneumonitis after total body irradiation]. (1991) (0)
- The use of multi-potent mesenchymal stromal cells for control of inflammatory bowel disease (2018) (0)
- 2232 Radiation therapy has a positive inhibitory effect on the growth of fungal infection: In vitro and in vivo results (1999) (0)
- Adoptive allogeneic cell-mediated immunotherapy and nonmyeloablative stem-cell transplantation (2000) (0)
- Role of mesenchymal stem cells in delivering Newcastle disease virus to glioma cells and glioma stem cells and enhancing the oncolytic effect of the virus by secreting TRAIL. (2013) (0)
- Potential elimination of multi-drug resistant cancer cells by targeted non-engrafting intentionally mismatched activated donor lymphocytes. (2019) (0)
- Successful treatment of murine and rat experimental autoimmune encephalomyelitis with lidomide, a novel immunomodulator (1993) (0)
- Long-Term Safety and Efficacy of Stem Cell Gene Therapy for ADA-SCID. (2006) (0)
- IMMUNOSUPPRESSION AND PERMANENT TRANSPLANTATION TOLERANCE ACROSS MAJOR HISTOCOMPATIBILITY BARRIERS FOLLOWING TOTAL LYMPHOID IRRADIATION (1979) (0)
- Transplant of ex vivo incubated bone marrow with rIL -7 for the enhancement of immuno-hematopoietic reconstitution (2015) (0)
- disease induced by allogeneic lymphocytes Use of trifunctional bispecific antibodies to prevent graft-versus-host (2011) (0)
- Is nonmyeloablative stem cell transplantation (Nst) Associated with increased risk of delayed hemolysis (2000) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Shimon Slavin?
Shimon Slavin is affiliated with the following schools: